Your search returned 10 results.

Results
	1.	Development of a physiologically based pharmacokinetic model for estradiol in rats and humans: a biologically motivated quantitative framework for evaluating responses to estradiol and other endocrine-active compounds. [electronic resource] by Plowchalk, David R Teeguarden, Justin Producer: 20030227 In: Toxicological sciences : an official journal of the Society of Toxicology vol. 69 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Prediction of drug clearance in a smoking population: modeling the impact of variable cigarette consumption on the induction of CYP1A2. [electronic resource] by Plowchalk, David R Rowland Yeo, Karen Producer: 20120914 In: European journal of clinical pharmacology vol. 68 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Pharmacokinetics, pharmacodynamics, and safety of bococizumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9, in healthy subjects when administered in co-mixture with recombinant human hyaluronidase: A phase 1 randomized trial. [electronic resource] by Bass, Almasa Plotka, Anna Mridha, Khurshid Sattler, Catherine Kim, Albert M Plowchalk, David R Publication details: Health science reports Sep 2018 In: Health science reports vol. 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Novel, selective vitamin D analog suppresses parathyroid hormone in uremic animals and postmenopausal women. [electronic resource] by Zella, Julia B Plum, Lori A Plowchalk, David R Potochoiba, Michael Clagett-Dame, Margaret DeLuca, Hector F Producer: 20150330 In: American journal of nephrology vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Drug metabolites as cytochrome p450 inhibitors: a retrospective analysis and proposed algorithm for evaluation of the pharmacokinetic interaction potential of metabolites in drug discovery and development. [electronic resource] by Callegari, Ernesto Kalgutkar, Amit S Leung, Louis Obach, R Scott Plowchalk, David R Tse, Susanna Producer: 20140624 In: Drug metabolism and disposition: the biological fate of chemicals vol. 41 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Results of bococizumab, a monoclonal antibody against proprotein convertase subtilisin/kexin type 9, from a randomized, placebo-controlled, dose-ranging study in statin-treated subjects with hypercholesterolemia. [electronic resource] by Ballantyne, Christie M Neutel, Joel Cropp, Anne Duggan, William Wang, Ellen Q Plowchalk, David Sweeney, Kevin Kaila, Nitin Vincent, John Bays, Harold Producer: 20150626 In: The American journal of cardiology vol. 115 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Comparison of different algorithms for predicting clinical drug-drug interactions, based on the use of CYP3A4 in vitro data: predictions of compounds as precipitants of interaction. [electronic resource] by Fahmi, Odette A Hurst, Susan Plowchalk, David Cook, Jack Guo, Feng Youdim, Kuresh Dickins, Maurice Phipps, Alex Darekar, Amanda Hyland, Ruth Obach, R Scott Producer: 20091019 In: Drug metabolism and disposition: the biological fate of chemicals vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	The sulfonylurea glipizide does not inhibit ischemic preconditioning in anesthetized rabbits. [electronic resource] by Flynn, David M Smith, Andrew H Treadway, Judith L Levy, Carolyn B Soeller, Walter C Boettner, Wayne A Wisniecki, Peter Plowchalk, David R Gernhardt, Steve S Tracey, W Ross Knight, Delvin R Producer: 20060606 In: Cardiovascular drugs and therapy vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Application of CYP3A4 in vitro data to predict clinical drug-drug interactions; predictions of compounds as objects of interaction. [electronic resource] by Youdim, Kuresh A Zayed, Aref Dickins, Maurice Phipps, Alex Griffiths, Michelle Darekar, Amanda Hyland, Ruth Fahmi, Odette Hurst, Susan Plowchalk, David R Cook, Jack Guo, Feng Obach, R Scott Producer: 20080723 In: British journal of clinical pharmacology vol. 65 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Simulation of human intravenous and oral pharmacokinetics of 21 diverse compounds using physiologically based pharmacokinetic modelling. [electronic resource] by Jones, Hannah M Gardner, Iain B Collard, Wendy T Stanley, Phil J Oxley, Penny Hosea, Natilie A Plowchalk, David Gernhardt, Steve Lin, Jing Dickins, Maurice Rahavendran, S Ravi Jones, Barry C Watson, Kenny J Pertinez, Henry Kumar, Vikas Cole, Susan Producer: 20110718 In: Clinical pharmacokinetics vol. 50 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)